QUORUM INNOVATIONS, LLC

Sarasota, FL · Biotech · Private

Biofilm-derived microbial peptide proteins formulated as an aerosolized respiratory therapeutic to prevent viral and bacterial adhesion to respiratory epithelium

quoruminnovations.com →
Grants
$1.2M
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
28
16 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase II · Anti-Adhesive Protein for Human Respiratory Surface Defense Against Respiratory Viruses and Pathogens$1,249,032
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2978BOLDEN THERAPEUTICS, INC.——
2979Navire Pharma——
2980POW GENETIC SOLUTIONS, INC.——
2981QUORUM INNOVATIONS, LLC——
2982NuPeak Therapeutics, Inc.——
2983SINGULAR IMMUNE, INC.——
2984GLOW THERAPEUTICS INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 16 granted of 28

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.